Humana Inc. (NYSE:HUM) Shares Sold by Schnieders Capital Management LLC

Schnieders Capital Management LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 550 shares of the insurance provider’s stock after selling 50 shares during the period. Schnieders Capital Management LLC’s holdings in Humana were worth $252,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Morgan Stanley increased its holdings in Humana by 6.2% in the 3rd quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider’s stock valued at $992,938,000 after purchasing an additional 119,760 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in Humana by 35.9% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock valued at $741,409,000 after purchasing an additional 402,559 shares in the last quarter. Northern Trust Corp increased its holdings in Humana by 5.1% in the 3rd quarter. Northern Trust Corp now owns 1,327,489 shares of the insurance provider’s stock valued at $645,850,000 after purchasing an additional 64,245 shares in the last quarter. Invesco Ltd. increased its holdings in Humana by 1.4% in the 3rd quarter. Invesco Ltd. now owns 965,488 shares of the insurance provider’s stock valued at $469,729,000 after purchasing an additional 13,670 shares in the last quarter. Finally, AQR Capital Management LLC increased its holdings in Humana by 39.3% in the 3rd quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider’s stock valued at $331,743,000 after purchasing an additional 192,546 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on HUM shares. StockNews.com cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Stephens decreased their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research report on Friday, January 26th. Jefferies Financial Group decreased their price objective on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday. TheStreet cut shares of Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. Finally, The Goldman Sachs Group reduced their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $454.63.

Humana Stock Performance

HUM traded down $12.00 on Wednesday, hitting $315.98. 3,343,745 shares of the company’s stock were exchanged, compared to its average volume of 2,004,982. The stock has a fifty day moving average of $329.86 and a two-hundred day moving average of $398.38. Humana Inc. has a twelve month low of $299.23 and a twelve month high of $541.21. The firm has a market cap of $38.12 billion, a PE ratio of 15.64, a P/E/G ratio of 1.91 and a beta of 0.45. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter last year, the business earned $9.38 earnings per share. Humana’s revenue was up 10.7% compared to the same quarter last year. On average, research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.12%. Humana’s dividend payout ratio is presently 17.86%.

Insider Activity at Humana

In other news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was purchased at an average price of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.29% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.